205 related articles for article (PubMed ID: 22998393)
1. Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use.
Hansen CT; Münster AM; Nielsen L; Pedersen P; Abildgaard N
Eur J Haematol; 2012 Dec; 89(6):458-68. PubMed ID: 22998393
[TBL] [Abstract][Full Text] [Related]
2. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population.
Abadie JM; Bankson DD
Ann Clin Lab Sci; 2006; 36(2):157-62. PubMed ID: 16682511
[TBL] [Abstract][Full Text] [Related]
3. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
Wolff F; Thiry C; Willems D
Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
[TBL] [Abstract][Full Text] [Related]
6. Serum free light chain reference values: a critical approach.
Altinier S; Seguso M; Zaninotto M; Varagnolo M; Adami F; Angeli P; Plebani M
Clin Biochem; 2013 May; 46(7-8):691-3. PubMed ID: 23384536
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
8. Biological variation of free light chains in serum.
Braga F; Infusino I; Dolci A; Panteghini M
Clin Chim Acta; 2013 Jan; 415():10-1. PubMed ID: 22981867
[No Abstract] [Full Text] [Related]
9. Serum free light chain analysis.
Davids MS; Murali MR; Kuter DJ
Am J Hematol; 2010 Oct; 85(10):787-90. PubMed ID: 20721885
[TBL] [Abstract][Full Text] [Related]
10. Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser.
Maisin D; Lepoutre T; Gruson D; Wallemacq P
Clin Biochem; 2013 May; 46(7-8):622-6. PubMed ID: 23291296
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
[TBL] [Abstract][Full Text] [Related]
12. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications.
Mohammed N; Chandran PA; Kandregula M; Mattaparthi RD; Gundeti S; Volturi J; Darapuneni R; Raju SB; Dattatreya PS
Asian Pac J Cancer Prev; 2016; 17(5):2605-10. PubMed ID: 27268638
[TBL] [Abstract][Full Text] [Related]
13. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study.
Cotten SW; Shajani-Yi Z; Cervinski MA; Voorhees T; Tuchman SA; Korpi-Steiner N
Clin Biochem; 2018 Aug; 58():100-107. PubMed ID: 29885308
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots.
Pretorius CJ; Klingberg S; Tate J; Wilgen U; Ungerer JP
Ann Clin Biochem; 2012 Sep; 49(Pt 5):450-5. PubMed ID: 22764186
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
16. [Progress in the management of multiple myeloma introduced by serum free light chain measurement].
Fuchida S; Shimazaki C
Nihon Rinsho; 2011 Dec; 69(12):2267-73. PubMed ID: 22242331
[TBL] [Abstract][Full Text] [Related]
17. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
18. Analytical performance of the serum free light chain assay.
Briand PY; Decaux O; Caillon H; Grosbois B; Le Treut A; Guenet L
Clin Chem Lab Med; 2010; 48(1):73-9. PubMed ID: 19929752
[TBL] [Abstract][Full Text] [Related]
19. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
Akar H; Seldin DC; Magnani B; O'Hara C; Berk JL; Schoonmaker C; Cabral H; Dember LM; Sanchorawala V; Connors LH; Falk RH; Skinner M
Amyloid; 2005 Dec; 12(4):210-5. PubMed ID: 16399645
[TBL] [Abstract][Full Text] [Related]
20. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
Jaskowski TD; Litwin CM; Hill HR
Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
